-
Mashup Score: 5AJCC Cancer Staging System Version 9: Appendiceal Adenocarcinoma - 3 hour(s) ago
Annals of Surgical Oncology –
Source: link.springer.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Advanced-Stage Classical Hodgkin Lymphoma - 3 day(s) ago
Classical Hodgkin lymphoma (HL) is a highly curable disease, but up to 25% of patients will develop relapsed or refractory classical HL. Although most patients achieve complete response following fron…
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 5
Nature – HRO761 is a potent, selective, allosteric WRN inhibitor that binds at the interface of the D1 and D2 helicase domains, locking WRN in an inactive conformation.
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Researchers may have uncovered how the long-term daily use of aspirin may help prevent the development and progression of colorectal cancer, according to a recent study.
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 13Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial - 6 day(s) ago
Nature Medicine – Treatment of patients with advanced hepatocellular carcinoma with a personalized DNA vaccine in combination with anti-PD-1 therapy was safe and led to encouraging clinical…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Medicare Advantage fight shifts to 340B arena - 6 day(s) ago
CMS should compel Medicare Advantage plans to retroactively adjust 340B payment rates, hospitals say.
Source: www.modernhealthcare.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6Primary Large B-cell Lymphomas of Immune-Privileged Sites - 7 day(s) ago
Diffuse large B-cell lymphoma (DLBCL) encompasses a diverse spectrum of aggressive B-cell lymphomas with remarkable genetic heterogeneity and myriad clinic
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4ESDO: esdo GI bullets - 9 day(s) ago
The addition of Pembrolizumab to perioperative chemotherapy increases the pCR rate, but does not improve the event-free survival (EFS) in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585). In a multicentre, randomised, placebo-controlled, phase III study, 1007 patients with locally advanced gastric or gastro-esophageal adenocarcinoma (≥cT3 i/lub N+) were randomly assigned to either the pembrolizumab plus perioperative chemotherapy group, or the placebo plus perioperative chemotherapy
Source: www.esdo.euCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10CCR8 expectations - 10 day(s) ago
Blockade of CCR8 has quietly emerged as a hot oncology target, especially for anti-PD-(L)1 MAb combinations.
Source: www.oncologypipeline.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 44
Platinum-based chemotherapy is the recommended adjuvant treatment for patients with resectable, ALK-positive non–small-cell lung cancer (NSCLC). Data on the efficacy and safety of adjuvant alectini…
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
RT @SyedAAhmad5: AJCC Cancer Staging System Version 9: Appendiceal Adenocarcinoma @AnnSurgOncol https://t.co/2JRplO8Eax